Tune in for a special presentation of the Best of Tuesday Talks. We will explore past conversations on what investors are looking to fund, how AI is used in drug discovery, and the groundbreaking treatments poised to revolutionize future cures. Don't miss this opportunity to learn from leading experts before our new season begins in September. #wewillcure
About us
Cure is a vibrant healthcare innovation campus in the heart of New York City with a mission to advance health. Supporting healthcare and life science entrepreneurs, Cure offers digital and in-person content, programming, and learnings on critical health and business topics. The campus at 345 Park Avenue South features laboratory and business facilities, office space and premium event venues, including an education center, conference center, and iconic rooftop terrace. Residents and members collaborate across the spectrum of healthcare and focus on diagnostic, device, drug development and production as well as care delivery and public health. For more information, please visit wewillcure.com.
- Website
-
www.wewillcure.com
External link for Cure.
- Industry
- Health and Human Services
- Company size
- 11-50 employees
- Headquarters
- New York, NY
- Type
- Privately Held
- Founded
- 2020
- Specialties
- Life Science, Incubator, Fellowships, healthcare, scientists, doctors, researchers, digitalhealth, science, health, startup, doctors , ecosystems, business, AI, education, cancer, entreprenuer, health equity, access to care, global health, artificial intelligence, events, and start-ups
Locations
-
Primary
345 Park Ave S
New York, NY 10010, US
Employees at Cure.
-
David Ewing Duncan
Journalist, Author, Researcher, Curator, and Advisor
-
Lauren Ruotolo
Creative Media Partnerships & Executive Producer | Content Thought Leadership, Strategic Direction
-
Paul Oestreicher
Strategic Communications; Public and Media Relations; Risk/Issues/Crisis/Reputation Management; Thought Leader; Mentor, and Trusted…
-
Charles Kim
COO & CFO | Healthcare, Sustainability, Food & Beverage
Updates
-
A recent Associated Press poll shows that 58% of US adults believe AI will amplify the spread of misinformation in the 2024 presidential election. Despite the risks, AI also has the potential to enhance civic engagement and strengthen the electoral system by increasing accessibility and reducing biases. On September 17, join us at The New York Academy of Sciences in NYC or virtually for Deepfakes and Democracy in the Age of AI! This even features a panel of experts from political consulting, social neuroscience, and deepfake technologies exploring AI's dual potential to bolster and undermine the political system. REGISTER TODAY: https://lnkd.in/dKgJrKes
-
-
Daria Lizneva, MD, PhD, Associate Professor at the Center for Translational Medicine and Pharmacology at the Icahn School of Medicine at Mount Sinai, has been named a finalist for the XSeed Award 2024 for her groundbreaking work in developing a new small molecule for long-term obesity management. Read more about how Lizneva is working to help the nearly 800M Obese people affected worldwide and why her team's work is crucial in addressing this major health concern. #wewillcure #obesityresearch #InnovationsInMedicine
-
Melissa Wallace co-founded Fierce Foundry in 2023 to build companies that improve women's lives and create a new investment flywheel for female founders. Read more to understand how Fierce Foundry co-founds new companies with capital investment plus services to ensure success at every stage. #femtech #femalefounders
Fierce Foundry’s Innovative Approach to Funding and Accelerating FemTech
wewillcure.com
-
Remember to tune in today at 12:30 pm EDT for the Best of Tuesday Talks. You'll hear from innovators, scientists, & entrepreneurs on the latest treatments, AI's role in drug discovery, maternal health stats, and how the vaginal microbiome could be the key to unlocking new treatments in women's health with George Church, Maria Luisa Pineda, PhD., Pita Navarro, William A Haseltine, Esther Dyson, Elizabeth Garner, and Matthieu Masselin Watch here: https://lnkd.in/e3jnNCzH
-
-
Women make up 51% of the population; however, they are underrepresented and understudied in medical research. Learn about why Carolee Lee founded Women's Health Access Matters and how her company is accelerating funding for women’s health research, which in turn benefits the economy. https://lnkd.in/eBZjeGvG
Carolee Lee on Why Increasing Women's Access to Healthcare Can Boost the Economy for All of Us
wewillcure.com
-
How do you make preventing illness as rewarding as delivering acute care for providers? Read more about the Advanced Research Projects Agency for Health (ARPA-H) HEROS program, which is creating a more equitable health outcomes for all Americans. #wewillcure
ARPA-H's HEROES Program Accelerates Preventive Health Innovations
wewillcure.com
-
Join us for an engaging live discussion from the 2023 United Nations Science Summit at Cure. We explored the intersection of science and global inclusion, how to make science more accessible to all, and the latest trends. #unga78 #linkedinlive #wewillcure
www.linkedin.com
-
RVO is the second most common cause of vision loss due to retinal vascular conditions. It affects more than 1M people in the U.S., mainly those aged 60 or older. Read more about how XSeed Award finalist Carol Troy MD, PhD, at Columbia University Irving Medical Center/Taub Institute for Research on Alzheimer's Disease, is developing a novel eye drop medication that could become the first noninvasive treatment for retinal vascular occlusion. #wewillcure
Spotlight on XSeed Award Finalist: Carol Troy, MD, PhD, Columbia University Neurologist
wewillcure.com